Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

14th International Myeloma Workshop /
Report from the Asian Myeloma Network

3rd - 7th Apr 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.04.13
Views: 5517

Dr J.H. Lee - Gachon University Gil Medical Center, Incheon, Republic of Korea

Dr J.H. Lee talks to ecancertv at IMW 2013 on the incidence of MM showing ethnic difference evidenced by US SEER and IARC data. Asians show lower incidence compared to Caucasian. However, there are growing evidences that MM is increasing in Asia.

The researchers collected 3,405 patient data from 22 centers of 7countries to build an Asian myeloma data base. Retrospective analyses were carried out to elucidate the presence of clinical and cytogenetic characteristics of MM in Asia. Median age was 62 years, 56% were male, bone lesion, severe anemia, thrombocytopenia, extramedullary plasmacytoma, hypercalcemia, hypoalbuminemia, renal dysfunction, increased LDH was observed in 80/39/8/16/19/52/23/28% respectively. IgG/A/LC was 55/22/17%. ISS was 20/36/44%.

Abnormal cytogenetics were observed in 33%, hypodiploid 15%, 13q deletion 12%, FISH analysis shows t (4; 14), t (11; 14), t (14; 16), del 17p, 11/17/4/13% respectively. OS was 47 months. Age, Hemoglobin, platelet, plasmacytoma, BMPC, calcium, albumin, creatinine, beta-2 MG, LDH, ISS, abnormal cytogenetics, 13q- by conventional cytogenetics, t(4;14) by FISH, ASCT, response to treatment, achievement of VGPR were prognostic variables for OS. Among them, azotemia, ISS, heavy chain, plasmacytoma, abnormal cytogenetics, ASCT, response to treatment remain as prognostic variables by multivariate analysis.

There were no unique clinical or cytogenetic characteristics identifies in Asian population. However, Dr Lee states that some unique findings, such as high incidence of del 17p in China, need to be explored in future study.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation